Pregnancy and opioids with Jerry Cochran

Pregnancy and opioids with Jerry Cochran

20:242023-12-05

Jaksokuvaus

In this episode Ben Scher talks to Professor Gerald (Jerry) Cochran about his article based on a randomized multisite pilot trial investigating the impact of Patient Navigation. Jerry begins by describing Patient Navigation, explaining how it works and how it can help people stay engaged in care. The research team explored whether this approach helps pregnant people to stay in contact with treatment services.Jerry then go on to discus the next steps for his research and explains how his research findings might be scaled up to influence policy. Jerry describes how Patient Navigation could be implemented within US Medicaid programmes summarising the data that would be needed to scale up the intervention. They then reflect on the economic implications for Medicade or state insurers."That's really exiting and it's really satisfying when you're able to identify a partner like a Medicaid programme or a large pharmacy chain.... and help them integrate into their workflow into their systems something that might help patients and think 'oh wow'. You know, not only could we help patients in a single clinic but we could help people in a state or across the country"Original article: Patient Navigation for Pregnant Persons with Opioid Use Disorder: Results of a Randomized Multisite Pilot Trial by Gerald Cochran and colleagues. Published in Addiction (2023)The opinions expressed in this podcast reflect the views of the hosts and authors and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information. Hosted on Acast. See acast.com/privacy for more information.

Tutustu

Lisää

  • Evästekäytäntö
  • Käyttöehdot
  • Tietosuojakäytäntöexternal link
  • Medialleexternal link
logo

© Podme AB 2024